Legal & General Group’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-8,372
| Closed | -$23K | – | 3553 |
|
|
2022
Q1 | $23K | Buy |
8,372
+316
| +4% | +$868 | ﹤0.01% | 3200 |
|
|
2021
Q4 | $35K | Sell |
8,056
-11,472
| -59% | -$49.8K | ﹤0.01% | 3106 |
|
|
2021
Q3 | $99K | Buy |
19,528
+9,942
| +104% | +$50.4K | ﹤0.01% | 2844 |
|
|
2021
Q2 | $60K | Buy |
9,586
+870
| +10% | +$5.45K | ﹤0.01% | 2890 |
|
|
2021
Q1 | $68K | Buy |
8,716
+2,001
| +30% | +$15.6K | ﹤0.01% | 2730 |
|
|
2020
Q4 | $44K | Hold |
6,715
| – | – | ﹤0.01% | 2836 |
|
|
2020
Q3 | $44K | Sell |
6,715
-1,947
| -22% | -$12.8K | ﹤0.01% | 2738 |
|
|
2020
Q2 | $72K | Buy |
8,662
+389
| +5% | +$3.23K | ﹤0.01% | 2616 |
|
|
2020
Q1 | $63K | Sell |
8,273
-2,549
| -24% | -$19.4K | ﹤0.01% | 2530 |
|
|
2019
Q4 | $90K | Buy |
10,822
+1,723
| +19% | +$14.3K | ﹤0.01% | 2627 |
|
|
2019
Q3 | $67K | Hold |
9,099
| – | – | ﹤0.01% | 2645 |
|
|
2019
Q2 | $102K | Buy |
9,099
+757
| +9% | +$8.49K | ﹤0.01% | 2517 |
|
|
2019
Q1 | $89K | Hold |
8,342
| – | – | ﹤0.01% | 2524 |
|
|
2018
Q4 | $126K | Buy |
8,342
+1,306
| +19% | +$19.7K | ﹤0.01% | 2409 |
|
|
2018
Q3 | $130K | Buy |
7,036
+934
| +15% | +$17.3K | ﹤0.01% | 2439 |
|
|
2018
Q2 | $139K | Buy |
6,102
+984
| +19% | +$22.4K | ﹤0.01% | 2395 |
|
|
2018
Q1 | $146K | Sell |
5,118
-2,128
| -29% | -$60.7K | ﹤0.01% | 2371 |
|
|
2017
Q4 | $155K | Hold |
7,246
| – | – | ﹤0.01% | 2412 |
|
|
2017
Q3 | $131K | Buy |
7,246
+798
| +12% | +$14.4K | ﹤0.01% | 2498 |
|
|
2017
Q2 | $101K | Buy |
6,448
+1,434
| +29% | +$22.5K | ﹤0.01% | 2601 |
|
|
2017
Q1 | $86K | Sell |
5,014
-247
| -5% | -$4.24K | ﹤0.01% | 2624 |
|
|
2016
Q4 | $58K | Buy |
5,261
+1,606
| +44% | +$17.7K | ﹤0.01% | 2842 |
|
|
2016
Q3 | $58K | Hold |
3,655
| – | – | ﹤0.01% | 2444 |
|
|
2016
Q2 | $36K | Buy |
+3,655
| New | +$36K | ﹤0.01% | 2636 |
|